Christopher Dunham

ORCID: 0000-0002-6244-0584
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Genomics and Diagnostics
  • Chromatin Remodeling and Cancer
  • Neuroblastoma Research and Treatments
  • Fetal and Pediatric Neurological Disorders
  • Sarcoma Diagnosis and Treatment
  • Neurofibromatosis and Schwannoma Cases
  • Hedgehog Signaling Pathway Studies
  • Cancer Mechanisms and Therapy
  • Ferroptosis and cancer prognosis
  • Cancer-related molecular mechanisms research
  • Microtubule and mitosis dynamics
  • Meningioma and schwannoma management
  • Brain Metastases and Treatment
  • Neonatal and fetal brain pathology
  • Autopsy Techniques and Outcomes
  • Vascular Malformations Diagnosis and Treatment
  • Spinal Dysraphism and Malformations
  • Vasculitis and related conditions
  • Neurogenetic and Muscular Disorders Research
  • Head and Neck Surgical Oncology
  • MicroRNA in disease regulation
  • RNA Research and Splicing
  • Gestational Trophoblastic Disease Studies

University of British Columbia
2016-2025

Children's & Women's Health Centre of British Columbia
2015-2025

British Columbia Children's Hospital
2014-2024

B.C. Women's Hospital & Health Centre
2024

Syracuse University
2023-2024

Deleted Institution
2022

University of Calgary
2006-2021

Wayne State University
2020

Howard Hughes Medical Institute
2018

University of California, Santa Cruz
2018

Infant gliomas have paradoxical clinical behavior compared to those in children and adults: low-grade tumors a higher mortality rate, while high-grade better outcome. However, we little understanding of their biology therefore cannot explain this nor what constitutes optimal management. Here report comprehensive genetic analysis an international cohort clinically annotated infant gliomas, revealing 3 subgroups. Group 1 arise the cerebral hemispheres harbor alterations receptor tyrosine...

10.1038/s41467-019-12187-5 article EN cc-by Nature Communications 2019-09-25
Jonathon Torchia Brian Golbourn Shengrui Feng King Ching Ho Patrick Sin‐Chan and 95 more Alexandre Vasiljevic Joseph Norman Paul Guilhamon Livia Garzia Natalia R. Agamez Mei Lu Tiffany Sin Yu Chan Daniel Picard Pasqualino de Antonellis Dong-Anh Khuong-Quang Aline Cristiane Planello Constanze Zeller Dalia Baršytė-Lovejoy Lucie Lafay‐Cousin Louis Létourneau Mathieu Bourgey Man Yu Deena M.A. Gendoo Misko Dzamba Mark Barszczyk Tiago da Silva Medina Alexandra N. Riemenschneider A. Sorana Morrissy Young‐Shin Ra Vijay Ramaswamy Marc Remke Christopher Dunham Stephen Yip Ho‐Keung Ng Jian‐Qiang Lu Vivek Mehta Steffen Albrecht José Pimentel Jennifer A. Chan Gino R. Somers Cláudia C. Faria Lúcia Roque Maryam Fouladi Lindsey M. Hoffman Andrew S. Moore Yin Wang Seung Ah Choi Jordan R. Hansford Daniel Catchpoole Diane K. Birks Nicholas K. Foreman Doug Strother Álmos Klekner László Bognár Miklós Garami Péter Hauser Tibor Hortobágyi Beverly Wilson Juliette Hukin Anne-Sophie Carret Timothy Van Meter Eugene Hwang Amar Gajjar Shih‐Hwa Chiou Hideo Nakamura Helen Toledano Iris Fried Daniel W. Fults Takafumi Wataya Chris Fryer David D. Eisenstat Katrin Scheinemann Adam Fleming Donna L. Johnston Jean Michaud Shayna Zelcer Robert Hammond Samina Afzal David A. Ramsay Nongnuch Sirachainan Suradej Hongeng Noppadol Larbcharoensub Richard G. Grundy Rishi Lulla Jason Fangusaro Harriet Druker Ute Bartels Ronald Grant David Malkin C. Jane McGlade Theodore Nicolaides Tarık Tihan Joanna J. Phillips Jacek Majewski Alexandre Montpetit Guillaume Bourque Gary D. Bader Alyssa Reddy G. Yancey Gillespie Monika Warmuth‐Metz

10.1016/j.ccell.2016.11.003 article EN publisher-specific-oa Cancer Cell 2016-12-01
Vijay Ramaswamy Thomas Hielscher Stephen C. Mack Álvaro Lassaletta Tong Lin and 95 more Kristian W. Pajtler David Jones Betty Luu Florence M.G. Cavalli Kenneth Aldape Marc Remke Martin Mynarek Stefan Rutkowski Sridharan Gururangan Roger E. McLendon Eric Lipp Christopher Dunham Juliette Hukin David D. Eisenstat Dorcas Fulton Frank van Landeghem Mariarita Santi Marie‐Lise C. van Veelen Erwin G. Van Meir Satoru Osuka Xing Fan Karin M. Muraszko Daniela Pretti da Cunha Tirapelli Sueli Mieko Oba‐Shinjo Suely Kazue Nagahashi Marie Carlos Gilberto Carlotti Ji Yeoun Lee Amulya A. Nageswara Rao Caterina Giannini Cláudia C. Faria Sofia Nunes Jaume Mora Ronald L. Hamilton Péter Hauser Nada Jabado Kevin Petrecca Shin Jung Luca Massimi Massimo Zollo Giuseppe Cinalli László Bognár Álmos Klekner Tibor Hortobágyi Sarah Leary Ralph Ermoian James M. Olson Jeffrey R. Leonard Corrine Gardner Wiesława Grajkowska Lola B. Chambless Jason Cain Charles G. Eberhart Sama Ahsan Maura Massimino Felice Giangaspero Francesca Romana Buttarelli Roger J. Packer Lyndsey Emery William H. Yong Horacio Soto Linda M. Liau Richard G. Everson Andrew J. Grossbach Tarek Shalaby Michael Grotzer Matthias A. Karajannis David Zagzag Helen Wheeler Katja von Hoff Marta M. Alonso T. Tuñón Ulrich Schüller Karel Zitterbart Jaroslav Štěrba Jennifer A. Chan Miguel A. Guzmán Samer K. Elbabaa Howard Colman Girish Dhall Paul G. Fisher Maryam Fouladi Amar Gajjar Stewart Goldman Eugene Hwang Marcel Kool Harshad Ladha Elizabeth Vera‐Bolanos Khalida Wani Frank S. Lieberman Tom Mikkelsen Antonio Omuro Ian F. Pollack Michael D. Prados H. Ian Robins Riccardo Soffietti

Posterior fossa ependymoma comprises two distinct molecular variants termed EPN_PFA and EPN_PFB that have a biology natural history. The therapeutic value of cytoreductive surgery radiation therapy for posterior after accounting subgroup is not known.Four independent nonoverlapping retrospective cohorts ependymomas (n = 820) were profiled using genome-wide methylation arrays. Risk stratification models designed based on known clinical newly described biomarkers identified by multivariable...

10.1200/jco.2015.65.7825 article EN Journal of Clinical Oncology 2016-06-07

Purpose High-grade gliomas (HGGs; WHO grades 3-4) are highly diverse, with survival times ranging from months to years. 2000 grading criteria for high-grade oligodendroglial neoplasms [anaplastic oligoastrocytoma (AOA) and anaplastic oligodendroglioma (AO)] remain subjective, the existence of grade 4 variants is controversial. Patients Methods Overall (OS) 1,093 adult patients a cerebral HGG newly diagnosed between 1990 2005 was analyzed by univariate multivariate models significance...

10.1200/jco.2006.08.1497 article EN Journal of Clinical Oncology 2006-11-30

Abstract Objective Spinal muscular atrophy (SMA) is an inherited neuromuscular disorder leading to paralysis and subsequent death in young children. Initially considered a motor neuron disease, extra‐neuronal involvement increasingly recognized. The primary goal of this study was investigate alterations lipid metabolism SMA patients mouse models the disease. Methods We analyzed clinical data collected from large cohort pediatric type I–III as well I liver necropsy data. In parallel, we...

10.1002/acn3.50855 article EN cc-by-nc-nd Annals of Clinical and Translational Neurology 2019-07-26

We sought to investigate clinical outcomes of relapsed medulloblastoma and compare molecular features between patient-matched diagnostic tumors.Children infants enrolled on either SJMB03 (NCT00085202) or SJYC07 (NCT00602667) trials who experienced relapse were analyzed for outcomes, including anatomic temporal patterns postrelapse survival. A largely independent, paired cohort was by DNA methylation array next-generation sequencing.A total 72 329 (22%) 52 79 (66%) patients with significant...

10.1200/jco.20.01359 article EN cc-by-nc-nd Journal of Clinical Oncology 2021-01-27
Christopher S. Chen Edward Franklin Y Li Nelly Joseph‐Mathurin Anthony S. Burns and 95 more G Wang Tammie L.S. Benzinger Randall J. Bateman Richard J. Perrin Sonal Agrawal Lei Yu Lisa L. Barnes David A. Bennett Julie A. Schneider Martha Clare Morris Genevieve Stein-O’Brien Ryan G. Palaganas Elaine C. Meyer Javier Redding‐Ochoa Olga Pletnikova H Guo William R. Bell Juan C. Troncoso Richard L. Huganir Adam Seth Levine Julie Bennett Chantel Cacciotti Samantha J DeMarsh Adriana Rodrigues Fonseca Guerreiro Stuecklin Jordan R. Hansford Louise E. Ludlow M. Aaron MacNeil Jean M. Mulcahy Levy Parag G. Patil Ashley Plant Beverley Wilson Fleming Richard Graham Joseline Haizel‐Cobbina Yoshiko Nakano Salmo Raskin Christopher Dunham Craig Erker C Li Mona Nasrallah E. C. Nelson Mohit Rana M Santi-Vicini Frank van Landeghem J Vel Azquez Vega Richard Yuditskiy Michael C. Dewan Uri Tabori Cynthia Hawkins Kenneth Aldape D. Hoang Elizabeth P. Shulman Emma M. Campagnolo Zied Abdullaev H Lalchungnunga Om V. Singh Eric A. Stone Eytan Ruppin Y. Zhu Darin D. Carabenciov D Johnson Jorge Trejo‐Lopez Andrew Nguyen A Raghunathan G Lanzino Cristiane M. Ida Zepeda Mendoza Giannini Mayo Professor Nikhil Patel Lynn M. Bekris Shane Formica Debby W. Tsuang Cyrus P. Zabetian Irene Litvan Jori Fleisher Sarah Berman David J. Irwin Andrea Bozoki Carol F. Lippa F. DiFillipo Lorna M. Lopez Douglas Galasko James B. Leverenz Marvin J. Miller C.M. Ma G Dong Suresh R. Naik Gannon A. McDonough Shaokuan Mao Ann C. McKee Annie Huang Anna F. Lee Yoshiaki MATSUMOTO D Silverbush

Background: Clinical trials of anti-Aβ monoclonal antibodies in Alzheimer disease (AD) infer target engagement from Aβ positron emission tomography (PET) and/or fluid biomarkers such as cerebrospinal (CSF) Aβ42/40.However, these measure deposits indirectly incompletely.In contrast, postmortem neuropathologic assessments allow direct investigation treatment effects on brain and many other pathologic features.Methods: From a clinical trial dominantly inherited AD, we measured...

10.1093/jnen/nlae036 article EN other-oa Journal of Neuropathology & Experimental Neurology 2024-05-10

West Nile virus (WNV) infection causes neurological disease at all levels of the neural axis, accompanied by neuroinflammation and neuronal loss, although underlying mechanisms remain uncertain. Given substantial activation neuroinflammatory pathways observed in WNV infection, we hypothesized that WNV-mediated cell death occurred through both glia neurons, which was driven part capsid protein expression. Analysis autopsied tissues from humans with encephalomyelitis (WNVE) revealed neurons...

10.1128/jvi.02422-06 article EN Journal of Virology 2007-08-02

Malignant peripheral nerve sheath tumors (MPNST) are highly aggressive sarcomas with variable patient survival and few known prognostically relevant genomic biomarkers. To identify survival-associated biomarkers, we performed high-resolution array-based comparative hybridization (aCGH) on a large set of MPNSTs.Candidate gene alterations identified by aCGH in 38 MPNSTs were validated at the DNA, RNA, protein levels these same an independent 87 MPNST specimens.aCGH revealed complex copy number...

10.1158/1078-0432.ccr-10-1551 article EN Clinical Cancer Research 2011-02-17

Abstract Medulloblastoma is the most common malignant brain tumor in children. This disease heterogeneous and composed of four subtypes medulloblastoma [WNT, Sonic Hedgehog (SHH), Group 3, 4]. An immediate goal to identify novel molecular targets for aggressive forms medulloblastoma. Polo-like kinase 1 (PLK1) an oncogenic that controls cell cycle proliferation, making it a strong candidate treatment. In this study, pediatric medulloblastomas were subtyped two patient cohorts (discovery...

10.1158/0008-5472.can-12-4331 article EN Cancer Research 2013-09-10

Aims DNA methylation‐based central nervous system (CNS) tumour classification has identified numerous molecularly distinct types, and clinically relevant subgroups among known CNS entities that were previously thought to represent homogeneous diseases. Our study aimed at characterizing a novel, defined variant of glioneuronal tumour. Patients methods methylation profiling was performed using the Infinium MethylationEPIC or 450 k BeadChip arrays (Illumina) analysed ‘conumee’ package in R...

10.1111/nan.12590 article EN cc-by-nc-nd Neuropathology and Applied Neurobiology 2019-12-23

Abstract The role for routine whole genome and transcriptome analysis (WGTA) poor prognosis pediatric cancers remains undetermined. Here, we characterize somatic mutations, structural rearrangements, copy number variants, gene expression, immuno-profiles germline cancer predisposition variants in children adolescents with relapsed, refractory or malignancies who underwent WGTA matched sequencing. Seventy-nine participants a median age at enrollment of 8.8 y (range 6 months to 21.2 y) are...

10.1038/s41467-024-48363-5 article EN cc-by Nature Communications 2024-05-16

Angiomatoid fibrous histiocytoma (AFH) is generally considered a soft tissue sarcoma of low malignant potential that occurs in children/young adults and most frequently affects the extremities. AFH infrequently recurs rarely metastasizes. has characteristic histomorphology, immunohistochemical reactivities for desmin CD68 have led to myofibroblastic fibrohistiocytic histogenetic hypotheses, respectively. Although only limited number cases been molecularly characterized, many demonstrated...

10.1097/pas.0b013e3181453451 article EN The American Journal of Surgical Pathology 2008-03-01

Glioblastoma multiforme (GBM) ranks among the deadliest types of cancer and given these new therapies are urgently needed. To identify molecular targets, we queried a microarray profiling 467 human GBMs discovered that polo-like kinase 1 (PLK1) was highly expressed in tumors it clustered with proliferative subtype. Patients PLK1-high were more likely to die from their disease suggesting current inactive against such tumors. This prompted us examine its expression brain tumor initiating cells...

10.1002/stem.1081 article EN Stem Cells 2012-03-13

Abstract Brain tumors represent the leading cause of childhood cancer mortality, which medulloblastoma (MB) is most frequent malignant tumor. Recent studies have demonstrated presence several MB molecular subgroups, each distinct in terms prognosis and predicted therapeutic response. Groups 1 2 are characterized by relatively good clinical outcomes activation Wnt Shh pathways, respectively. In contrast, groups 3 4 (“non-Shh/Wnt MBs”) distinguished metastatic disease, poor patient outcome,...

10.1002/stem.1401 article EN Stem Cells 2013-04-17

While international consensus and the 2021 WHO classification recognize multiple molecular medulloblastoma subgroups, these are difficult to identify in clinical practice utilizing routine approaches. As a result, biology-driven risk stratification therapy assignment for remains major challenge. Here, we report mass spectrometry-based analysis of samples subgroup discovery, highlighting MYC-driven prognostic signature MYC immunohistochemistry (IHC) as clinically tractable method improved...

10.1093/neuonc/noaf046 article EN PubMed 2025-03-05

Molecular profiling of tumors has proven to be a valuable tool for identification prognostic and diagnostic subgroups in medulloblastomas, glioblastomas, other cancers. However, the molecular landscape atypical teratoid/rhabdoid (AT/RTs) remains largely unexplored. To address this issue, we used microarrays measure gene expression profiles 18 AT/RTs performed unsupervised hierarchical clustering determine molecularly similar subgroups. Four major (clusters) were identified. These did not...

10.1093/neuonc/nor140 article EN Neuro-Oncology 2011-09-23

Abstract Background Rhabdoid tumors (RTs) are aggressive of early childhood that occur most often in brain (AT/RTs) or kidney (KRTs). Regardless location, they characterized by loss functional SMARCB1 protein, a component the SWI/SNF chromatin remodeling complex. The aim this study was to determine genes and biological process dysregulated common both AT/RTs KRTs. Procedure Gene expression for compared other normal using microarray data from our lab. Similar analysis performed KRTs GEO....

10.1002/pbc.24481 article EN Pediatric Blood & Cancer 2013-02-04
Coming Soon ...